Biogen (BIIB) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 9, 2026, to be held virtually for shareholder participation.

• Shareholders are invited to vote on key proposals, including director elections, auditor ratification, and executive compensation.

Voting matters and shareholder proposals

• Election of 10 directors for a one-year term until the 2027 annual meeting, with all nominees recommended by the board.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation (Say on Pay) included.

• Provision to transact other business as may be properly brought before the meeting.

Board of directors and corporate governance

• Ten nominees listed for board election, each recommended for approval.

• Directors to serve one-year terms, with succession until the 2027 annual meeting.